Mike Kuranda
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, DNA Repair Mechanisms, Mitochondrial Function and Pathology, Nutrition, Genetics, and Disease, ATP Synthase and ATPases Research
Most-Cited Works
- → A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment(2018)441 cited
- → Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways(2014)50 cited
- → Screening Systems for Detecting Inhibitors of Cell Wall Transglycosylation in Enterococcus.Cell Wall Transglycosylation Inhibitors in Enterococcus.(1998)32 cited
- → Identification of Compounds That Inhibit Late Steps of Peptidoglycan Synthesis in Bacteria.(2002)28 cited
- → Analysis of two pharmacodynamic biomarkers using acoustic micro magnetic particles on the ViBE bioanalyzer(2010)12 cited
- → Use of combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 on the growth of BRAF-mutant and RAS-mutant preclinical models of melanoma and CRC.(2013)2 cited
- → Abstract C146: Combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 inhibits the growth of BRAF mutant and RAS mutant preclinical models of melanoma and CRC.(2013)2 cited
- → Abstract C55: Nedd8-activating enzyme inhibitor pevonedistat synergizes with cisplatin and carboplatin through interference with nucleotide excision repair and interstrand cross-link repair mechanisms in non-small cell lung cancer(2015)2 cited
- → Abstract 1423: Nedd8-activating enzyme inhibitor pevonedistat synergizes with cisplatin and carboplatin through interference with nucleotide excision repair and interstrand cross-link repair mechanisms in non-small cell lung cancer(2017)
- → Supplementary Table 1 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways(2023)